                         SEQUENCE LISTING

<110>  Pharis Biotec GmbH
       FRIEDRICH-ALEXANDER-UNIVERSITT ERLANGEN-NRNBERG
 
<120>  Polypeptide for the therapy of glomerular kidney disease and analysis of the course and prognosis of dependent syndromes

<130>  210141WO

<150>  EP20163836.8

<151>  2020-03-18

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  127
<212>  PRT
<213>  human

<400>  1

Lys Glu Ser Arg Ala Lys Lys Phe Gln Arg Gln Met Asp Ser Asp Ser 
1               5                   10                  15      


Ser Pro Ser Ser Ser Ser Thr Tyr Cys Asn Gln Met Met Arg Arg Arg 
            20                  25                  30          


Asn Met Thr Gln Gly Arg Cys Lys Pro Val Asn Thr Phe Val His Glu 
        35                  40                  45              


Pro Leu Val Asp Val Gln Asn Val Cys Phe Gln Glu Lys Val Thr Cys 
    50                  55                  60                  


Lys Asn Gly Gln Gly Asn Cys Tyr Lys Ser Asn Ser Ser Met His Ile 
65                  70                  75                  80  


Thr Asp Cys Arg Leu Thr Asn Gly Ser Arg Tyr Pro Asn Cys Ala Tyr 
                85                  90                  95      


Arg Thr Ser Pro Lys Glu Arg His Ile Ile Val Ala Cys Glu Gly Ser 
            100                 105                 110         


Pro Tyr Val Pro Val His Phe Asp Ala Ser Val Glu Asp Ser Thr 
        115                 120                 125         


<210>  2
<211>  155
<212>  PRT
<213>  human

<400>  2

Met Ala Leu Glu Lys Ser Leu Val Arg Leu Leu Leu Leu Val Leu Ile 
1               5                   10                  15      


Leu Leu Val Leu Gly Trp Val Gln Pro Ser Leu Gly Lys Glu Ser Arg 
            20                  25                  30          


Ala Lys Lys Phe Gln Arg Gln Met Asp Ser Asp Ser Ser Pro Ser Ser 
        35                  40                  45              


Ser Ser Thr Tyr Cys Asn Gln Met Met Arg Arg Arg Asn Met Thr Gln 
    50                  55                  60                  


Gly Arg Cys Lys Pro Val Asn Thr Phe Val His Glu Pro Leu Val Asp 
65                  70                  75                  80  


Val Gln Asn Val Cys Phe Gln Glu Lys Val Thr Cys Lys Asn Gly Gln 
                85                  90                  95      


Gly Asn Cys Tyr Lys Ser Asn Ser Ser Met His Ile Thr Asp Cys Arg 
            100                 105                 110         


Leu Thr Asn Gly Ser Arg Tyr Pro Asn Cys Ala Tyr Arg Thr Ser Pro 
        115                 120                 125             


Lys Glu Arg His Ile Ile Val Ala Cys Glu Gly Ser Pro Tyr Val Pro 
    130                 135                 140                 


Val His Phe Asp Ala Ser Val Glu Asp Ser Thr 
145                 150                 155 


<210>  3
<211>  28
<212>  PRT
<213>  human

<400>  3

Met Ala Leu Glu Lys Ser Leu Val Arg Leu Leu Leu Leu Val Leu Ile 
1               5                   10                  15      


Leu Leu Val Leu Gly Trp Val Gln Pro Ser Leu Gly 
            20                  25              


